Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • A novel approach to improve...
    Davidoff, Amy J; Zuckerman, Ilene H; Pandya, Naimish; Hendrick, Franklin; Ke, Xuehua; Hurria, Arti; Lichtman, Stuart M; Hussain, Arif; P.Weiner, Jonathan; Edelman, Martin J

    Journal of geriatric oncology, 04/2013, Volume: 4, Issue: 2
    Journal Article

    Abstract Objectives To develop and provide initial validation for a multivariate, claims-based prediction model for disability status (DS), a proxy measure of performance status (PS), among older adults. The model was designed to augment information on health status at the point of cancer diagnosis in studies using insurance claims to examine cancer treatment and outcomes. Materials and Methods We used data from the 2001–2005 Medicare Current Beneficiary Survey (MCBS), with observations randomly split into estimation and validation subsamples. We developed an algorithm linking self-reported functional status measures to a DS scale, a proxy for the Eastern Cooperative Oncology Group (ECOG) PS scale. The DS measure was dichotomized to focus on good ECOG 0–2 versus poor ECOG 3–4 PS. We identified potential claims-based predictors, and estimated multivariate logistic regression models, with poor DS as the dependent measure, using a stepwise approach to select the optimal model. Construct validity was tested by determining whether the predicted DS measure generated by the model was a significant predictor of survival within a validation sample from the MCBS. Results and Conclusion One-tenth of the beneficiaries met the definition for poor DS. The base model yielded high sensitivity (0.79) and specificity (0.92); positive predictive value = 48.3% and negative predictive value = 97.8%, c-statistic = 0.92 and good model calibration. Adjusted poor claims-based DS was associated with an increased hazard of death (HR = 3.53, 95% CI 3.18, 3.92). The ability to assess DS should improve covariate control and reduce indication bias in observational studies of cancer treatment and outcomes based on insurance claims.